Invizius’s Pioneering Dialysis Product H-Guard® Completes First In-Human Clinical StudyHannah Andrews2024-05-22T17:47:50+01:00May 22nd, 2024|News|
Pioneer Group Announces Landmark Partnership With The Crown Estate & Oxford Science EnterprisesSteve Jarvis2024-08-12T10:45:52+01:00May 22nd, 2024|Headline News, Investment, News|
CHAIN Biotech Announces Collaboration With The Prestigious German Cancer Research Centre DKFZ For The Development Of A Novel Oncology VaccineHannah Andrews2024-11-21T10:40:36+00:00April 16th, 2024|News|
BioAscent Reports Promising Growth As It Marks Tenth AnniversarySteve Jarvis2024-11-28T14:23:27+00:00April 15th, 2024|BioCity Glasgow, Investment, News|
University Of Oxford Spin-Out Named Winner Of ‘Golden Ticket’ Programme For Planetary Health InnovationsSteve Jarvis2024-11-28T14:23:49+00:00April 12th, 2024|Accelerator, Investment, News|
Cranfield-Colworth Innovation Challenge: A Triumph Of Innovation & SustainabilitySteve Jarvis2024-11-28T15:20:56+00:00March 22nd, 2024|Colworth Park, Investment, News|
Scotland’s Thriving Life Sciences Sector Defies PredictionsSteve Jarvis2024-03-21T15:55:33+00:00March 21st, 2024|BioCity Glasgow, Edinburgh Technopole, Investment, News|
Pioneer Group Leads $2.34m Investment In Neobe Therapeutics’ Cancer Therapy InnovationSteve Jarvis2024-11-28T14:25:26+00:00February 29th, 2024|Investment, News|
BioCity Glasgow: BioAscent Invests In New State-Of-The-Art Protein Production FacilitySteve Jarvis2024-11-28T14:25:44+00:00February 23rd, 2024|BioCity Glasgow, Investment, News|
